论文部分内容阅读
从１９８５年５月～１９９２年１２月，作者共收集了１１４例大肠癌死亡病例资料，发现Ｄｕｋｅ′ｓ分期是影响大肠癌生存期的关键。大肠癌的病理类型也影响生存期，以乳头状腺癌患者生存期最长。治疗方案不同也影响生存期。Ｄｕｋｅ′ｓＢ期大肠癌思考，以作单纯根治切除者生存期最长；Ｄｕｋｅ′ｓＣ期大肠癌以作根治切除加辅助化疗者生存期最长；Ｄｕｋｅ′ｓＤ期大肠癌以根治性放疗生存期最长，其次为作姑息性切除和单纯化疗者。对术后复发和远处器官转移倘能作局部切除者，应争取再次手术治疗。
From May 1985 to December 1992, the authors collected 114 cases of colorectal cancer deaths, and found that Duke’s staging is the key to the survival of colorectal cancer. The pathological type of colorectal cancer also affects the survival period, with the longest survival period for patients with papillary adenocarcinoma. Different treatment options also affect survival. Duke’s stage B colorectal cancer is thought to have the longest survival time for radical radical resection; Duke’s C stage colorectal cancer for radical resection plus adjuvant chemotherapy has the longest survival time; Duke’s D stage colorectal cancer is treated with radical radiotherapy. The longest, followed by palliative resection and chemotherapy alone. For local resection of postoperative recurrence and distant organ metastases, reoperation should be pursued.